This bill mandates that health care facilities in New Jersey report all known and suspected cases of amyotrophic lateral sclerosis (ALS) to the Department of Health. The reporting must be done confidentially and in accordance with federal and state privacy laws, with specific procedures to be outlined by the department. The information collected will be used solely for research purposes.

The bill aims to enhance the understanding and research of ALS by ensuring that comprehensive data is gathered from licensed health care facilities. It is designed to take effect immediately upon enactment, emphasizing the urgency of tracking this condition for better health outcomes and research initiatives.